Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

CKPT

Checkpoint Therapeutics (CKPT)

Checkpoint Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CKPT
DataHoraFonteTítuloCódigoCompanhia
24/05/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202417:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CKPTCheckpoint Therapeutics Inc
14/05/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
10/05/202417:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
05/02/202419:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CKPTCheckpoint Therapeutics Inc
30/01/202419:10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CKPTCheckpoint Therapeutics Inc
27/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CKPTCheckpoint Therapeutics Inc
17/11/202319:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202317:01GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202318:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202318:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CKPTCheckpoint Therapeutics Inc
15/05/202317:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CKPTCheckpoint Therapeutics Inc
15/05/202317:01GlobeNewswire Inc.Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:CKPTCheckpoint Therapeutics Inc
01/05/202317:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CKPTCheckpoint Therapeutics Inc
21/04/202317:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CKPTCheckpoint Therapeutics Inc
19/04/202317:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CKPTCheckpoint Therapeutics Inc
14/04/202318:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CKPTCheckpoint Therapeutics Inc
06/04/202318:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CKPTCheckpoint Therapeutics Inc
04/04/202317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CKPTCheckpoint Therapeutics Inc
31/03/202317:37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CKPTCheckpoint Therapeutics Inc
30/03/202317:10GlobeNewswire Inc.Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate HighlightsNASDAQ:CKPTCheckpoint Therapeutics Inc
14/02/202314:23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CKPTCheckpoint Therapeutics Inc
09/12/202219:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CKPTCheckpoint Therapeutics Inc
04/11/202218:23Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)NASDAQ:CKPTCheckpoint Therapeutics Inc
12/08/202212:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Checkpoint Therapeutics (CKPT)NASDAQ:CKPTCheckpoint Therapeutics Inc
16/06/202211:35TipRanksH.C. Wainwright Thinks Checkpoint Therapeutics’ Stock is Going to RecoverNASDAQ:CKPTCheckpoint Therapeutics Inc
29/04/202209:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CKPTCheckpoint Therapeutics Inc
01/04/202209:30GlobeNewswire Inc.Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022NASDAQ:CKPTCheckpoint Therapeutics Inc
07/05/202118:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CKPTCheckpoint Therapeutics Inc
18/09/202007:05Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:CKPTCheckpoint Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CKPT

Seu Histórico Recente

Delayed Upgrade Clock